BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

910 related articles for article (PubMed ID: 12721238)

  • 1. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.
    Segal RJ; Reid RD; Courneya KS; Malone SC; Parliament MB; Scott CG; Venner PM; Quinney HA; Jones LW; D'Angelo ME; Wells GA
    J Clin Oncol; 2003 May; 21(9):1653-9. PubMed ID: 12721238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer.
    Segal RJ; Reid RD; Courneya KS; Sigal RJ; Kenny GP; Prud'Homme DG; Malone SC; Wells GA; Scott CG; Slovinec D'Angelo ME
    J Clin Oncol; 2009 Jan; 27(3):344-51. PubMed ID: 19064985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial.
    Galvão DA; Taaffe DR; Spry N; Joseph D; Newton RU
    J Clin Oncol; 2010 Jan; 28(2):340-7. PubMed ID: 19949016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study.
    Hansen PA; Dechet CB; Porucznik CA; LaStayo PC
    PM R; 2009 Nov; 1(11):1019-24. PubMed ID: 19942188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.
    Galvão DA; Spry NA; Taaffe DR; Newton RU; Stanley J; Shannon T; Rowling C; Prince R
    BJU Int; 2008 Jul; 102(1):44-7. PubMed ID: 18336606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute versus chronic exposure to androgen suppression for prostate cancer: impact on the exercise response.
    Galvão DA; Taaffe DR; Spry N; Joseph D; Newton RU
    J Urol; 2011 Oct; 186(4):1291-7. PubMed ID: 21849187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer.
    Joly F; Alibhai SM; Galica J; Park A; Yi QL; Wagner L; Tannock IF
    J Urol; 2006 Dec; 176(6 Pt 1):2443-7. PubMed ID: 17085125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial.
    Courneya KS; Segal RJ; Mackey JR; Gelmon K; Reid RD; Friedenreich CM; Ladha AB; Proulx C; Vallance JK; Lane K; Yasui Y; McKenzie DC
    J Clin Oncol; 2007 Oct; 25(28):4396-404. PubMed ID: 17785708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer.
    Buffart LM; Galvão DA; Chinapaw MJ; Brug J; Taaffe DR; Spry N; Joseph D; Newton RU
    Cancer; 2014 Jan; 120(2):294-301. PubMed ID: 24122296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy.
    Herr HW; O'Sullivan M
    J Urol; 2000 Jun; 163(6):1743-6. PubMed ID: 10799173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis risk and interest in strength training in men receiving androgen ablation therapy for locally advanced prostate cancer.
    Ott C; Fulton MK
    J Am Acad Nurse Pract; 2005 Mar; 17(3):113-22. PubMed ID: 15748224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer.
    Smith MR
    Urology; 2004 Apr; 63(4):742-5. PubMed ID: 15072892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial.
    Courneya KS; McKenzie DC; Mackey JR; Gelmon K; Reid RD; Friedenreich CM; Ladha AB; Proulx C; Vallance JK; Lane K; Yasui Y; Segal RJ
    Cancer; 2008 Apr; 112(8):1845-53. PubMed ID: 18306372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in multiple health outcomes at 12 and 24 weeks resulting from 12 weeks of exercise counseling with or without dietary counseling in obese adults.
    Melanson KJ; Dell'Olio J; Carpenter MR; Angelopoulos TJ
    Nutrition; 2004 Oct; 20(10):849-56. PubMed ID: 15474871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy.
    Monga U; Garber SL; Thornby J; Vallbona C; Kerrigan AJ; Monga TN; Zimmermann KP
    Arch Phys Med Rehabil; 2007 Nov; 88(11):1416-22. PubMed ID: 17964881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen deprivation therapy for prostate cancer: effects on hand function.
    Soyupek F; Soyupek S; Perk H; Ozorak A
    Urol Oncol; 2008; 26(2):141-6. PubMed ID: 18312932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation.
    Galvão DA; Taaffe DR; Spry N; Joseph D; Turner D; Newton RU
    Prostate Cancer Prostatic Dis; 2009; 12(2):198-203. PubMed ID: 18852703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer.
    Galvão DA; Taaffe DR; Spry N; Newton RU
    Prostate Cancer Prostatic Dis; 2007; 10(4):340-6. PubMed ID: 17486110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.